Key result
High-risk hs-CRP persists in 23% of non-diabetic COVID-19 ICU survivors and correlates with fasting blood sugar.
Why the study?
The long-term extrapulmonary sequelae of COVID-19 after ICU recovery and the prognostic value of hs-CRP for cardiovascular disease in non-diabetic patients are unclear.
Does elevated hs-CRP correlate with fasting blood sugar and indicate cardiovascular risk in non-diabetic COVID-19 ICU survivors at 1-year follow-up?
Cohort (n=26)
No
Does elevated hs-CRP correlate with fasting blood sugar and indicate cardiovascular risk in non-diabetic COVID-19 ICU survivors at 1-year follow-up?
Answers are grounded in this paper and cite their sources.
Elevated hs-CRP persists in a significant proportion of non-diabetic COVID-19 ICU survivors at one year, correlating with fasting blood sugar and suggesting a potential ongoing risk for cardiovascular disease.
OBJECTIVE: The long-term extrapulmonary sequelae of COVID-19 after recovery from the critical stage at the intensive care unit (ICU) are still unclear. Some post-COVID symptoms are prevalent even after a one-year follow-up. To explore the relationship between high sensitivity C-reactive protein (hs-CRP) and hyperglycemia with cardiovascular diseases in non-diabetic COVID-19 patients. To determine whether increased fasting blood sugar (FBS) levels are associated with elevated hs-CRP and to explore whether hs-CRP can serve as a prognostic indicator to predict cardiovascular outcome. METHODS: FBS and hs-CRP values of 26 non-diabetic COVID-19 patients were collected from their medical records at JIPMER hospital. In one-year follow-up of these 26 patients, 2mL of blood sample was collected for the analysis of FBS, HbA1c, and hs-CRP. RESULTS: hs-CRP increased in 23% of follow-up patients who were at high risk, and 42.3% of participants were at average risk for cardiovascular disease. High and average-risk groups of survivors showed a positive correlation of hs-CRP with FBS and HbA1c levels, and these patients should be carefully monitored. CONCLUSION: ICU survivors with elevated hs-CRP need periodic check-ups for cardiovascular diseases. We suggest that hs-CRP could be used as an early prognostic indicator of cardiovascular diseases and can reduce the risk.
No takes yet. Share an insight, caveat, or question.
Kandhasami et al. (2023) conducted a cohort in Severe Non-Diabetic COVID-19 (n=26). Severe COVID-19 requiring ICU admission was evaluated on Correlation between fasting blood sugar and hs-CRP at one-year follow-up (r=0.48, p=0.013). At one-year follow-up, 23% of non-diabetic severe COVID-19 ICU survivors had high-risk hs-CRP levels, which positively correlated with fasting blood sugar levels.
Synapse has enriched 10 related papers. Consider them for comparative context: